Načítá se...
Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
BACKGROUND: The use of stereotactic body radiotherapy (SBRT) as the primary treatment modality in clinically localized prostate cancer (PCa) is emerging. The aim of the study was to analyze the long-term results of PCa patients treated with SBRT. METHODS: This non-selected, real-life patient cohort...
Uloženo v:
| Vydáno v: | Radiat Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7362647/ https://ncbi.nlm.nih.gov/pubmed/32664981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-020-01608-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|